Wird geladen...

Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer

Costimulatory pathway ligands and receptors can deliver either positive or negative signals to help determine the ultimate fate of activated T lymphocytes. Cytotoxic T lymphocyte antigen-4 (CTLA-4) represents one of the most extensively studied receptors in the costimulatory pathway and has recently...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Thompson, R. Houston, Allison, James P., Kwon, Eugene D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2006
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1976273/
https://ncbi.nlm.nih.gov/pubmed/16962497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2005.08.011
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!